|
|
 |
|
Supervisory Board
- M. François MICELI, Chief Executive Officer IMAXIO (President of the Board)
- M. Philippe ARCHINARD, CEO Transgène and Scientific Director Mérieux Alliance Group
- M. Stéphane BOISSEL, Vice-President Innate Pharma
- M. Lennart BRUCE, VIKEN Pharma Consulting
- M. Thierry LAUGEL, representing AGF Private Equity
- M. Franck LESCURE, representing AURIGA Partners
- M. Glenn RICHARD, representing AXA Private Equity
|
|
|
|
